Another 9 years were needed to identify filamentous alpha-synuclein (a-syn) as a component of GCIs linking MSA with Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) within the group of a-synucleinopathies [3–5]. Here, SNCA is linked to Parkinson disease.